Best Glioma doctors in Turkey: TOP 23 doctors

Dr. Eda Tanrikulu specializes in medical oncology and chemotherapy, with a strong focus on glioma treatment at Anadolu Medical Center.

• Completed medical oncology training at Marmara University
• Ranked 3rd in Turkey in minor specialty exam
• Led medical oncology unit at Haydarpaşa Numune Training and Research Hospital
• Participated in numerous international clinical studies

Dr. Mustafa Solak specializes in complex cancers at Hisar Hospital Intercontinental, with fellowship training at Hacettepe University Cancer Institute.

• Deals with breast, lung, and gastrointestinal cancers
• Fellowship-trained at The University of Texas MD Anderson Cancer Center
• Residency at Istanbul Sisli Etfal Training and Research Hospital

Specialist Dr. Rahib Hasanov brings international oncology expertise from Houston Methodist Hospital and Marmara University to Hisar Hospital Intercontinental.

• Completed Medical Oncology fellowship with focus on modern treatments
• Specializes in personalized oncology, including immunotherapies and targeted therapies
• Regularly treats international patients from Europe and the US
• Attends global oncology congresses to stay current with latest advancements

Dr. Yildiz has over a decade of specialist oncology experience, focusing on advanced cancer cases at Medipol Mega University Hospital.

• Over 15 years of experience in medical oncology
• Holds a professorship in oncology – an expert who trains other doctors
• Published extensively in international medical journals on various cancers
• Member of the European Society for Medical Oncology (ESMO)
• Special interest in neuroendocrine tumors and complex case management

Prof. Sezer Sağlam specializes in medical oncology with a focus on glioma treatment at Gayrettepe Florence Nightingale Hospital.

• Professor in Medical Oncology since 2016
• Fellowship-trained at Istanbul University
• Member of ESMO, ASCO, and Turkish Medical Oncology Association

Professor Doctor Sefik Igdem specializes in advanced radiation oncology for brain tumors at Gayrettepe Florence Nightingale Hospital.

• Expert in Truebeam Stx and Halcyon technologies
• Subspecialty focus on head and neck cancers
• Professor at T.R Demiroğlu Bilim University
• Trained at Istanbul University Cerrahpaşa Faculty of Medicine

Abdullah Sakin leads the medical oncology department at Medipol Bahçelievler Hospital, specializing in glioma treatment.

• Head of Medical Oncology at Yüzüncü Yıl University Faculty of Medicine
• Trained in medical oncology at Istanbul Okmeydanı Training and Research Hospital
• Specialist in internal medicine with extensive oncology experience

Dr. Tahsin Ozadli specializes in glioma and other complex cancers, bringing expertise from Ankara Oncology Training and Research Hospital.

• Medical oncology specialization with focus on brain tumors
• Experience at Ankara Oncology Hospital's Medical Oncology Clinic
• Published researcher with work accessible via Google Scholar

Assoc. Prof. Nail Paksoy is a medical oncologist specializing in glioma treatment at Medipol Bahçelievler Hospital, with ESMO Board Certification and extensive research experience.

• Fellowship-trained at Istanbul University Oncology Institute
• Participated in 8 international clinical trials for cancer treatments
• Published multiple studies on brain tumors and neuro-oncology
• ESMO Board Certified in Medical Oncology

Prof. Engin brings 30+ years of radiation oncology expertise, including leadership roles at top institutions like Anadolu Medical Center and Uludağ University.

• Fellowship-trained at Thomas Jefferson University in thermoradiotherapy
• Former Chairman of Radiation Oncology at Uludağ University
• Specializes in advanced radiation techniques for brain tumors
• Published research on occupational cancer risks at NIH

Dr. Mehmet Ozek brings 23+ years of neurosurgical expertise with a focus on endoscopic skull base surgery and functional neurosurgery.

• Specializes in endoscopic techniques for glioma treatment
• Fellowship-trained at Florida University and Yale University
• Published 47 articles in SCI international journals
• Member of AANS and Turkish Neurosurgery Association

Associate Professor Dr. Emrah Eraslan specializes in oncology, with extensive experience in treating various cancers at Koru Ankara Hospital.

• Board-certified in medical oncology since 2011
• Trained at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital
• Focuses on breast, prostate, lung, colorectal, stomach, and ovarian cancers
• Published multiple research papers in oncology

Professor in Medical Oncology with a focus on gastrointestinal tumors – Dr. Sezer Saglam brings deep expertise to complex glioma cases at Florence Nightingale Hospital.

• 20+ years in medical oncology with fellowship training at Istanbul University
• Specializes in gastrointestinal oncology since 2005
• Member of ESMO, ASCO and European Neuroendocrine Tumor Society
• Currently practices at Gayrettepe Florence Nightingale Hospital

Dr. Alemdar specializes in Medical Oncology with extensive training at Akdeniz University – a leader in oncology care.

• Board-certified in Medical Oncology since 2018
• Over 15 years of experience in oncology
• Works at Medical Park Antalya Hospital Complex

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.